253 related articles for article (PubMed ID: 26821240)
21. Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients - subgroup analyses from three European clinical trials.
Sabatowski R; Bösl I; König S; Buchheister B; Meier T; Baron R
Curr Med Res Opin; 2017 Mar; 33(3):595-603. PubMed ID: 28035844
[TBL] [Abstract][Full Text] [Related]
22. The Analgesic and Emotional Response to Intravenous Lidocaine Infusion in the Treatment of Postherpetic Neuralgia: A Randomized, Double-Blinded, Placebo-controlled Study.
Liu H; Lu F; Zhou D; Yin Y; Li J; Yang B; Song L; Ye L; Xiao H
Clin J Pain; 2018 Nov; 34(11):1025-1031. PubMed ID: 29698250
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom.
Dakin H; Nuijten M; Liedgens H; Nautrup BP
Clin Ther; 2007 Jul; 29(7):1491-507. PubMed ID: 17825701
[TBL] [Abstract][Full Text] [Related]
24. Use of 5% lidocaine medicated plasters for the treatment of pain in routine hospital practice: patient reported pain, functioning and satisfaction.
Khot S; Morgan CL; Kadambande S; Poole CD
Curr Med Res Opin; 2014 Aug; 30(8):1573-8. PubMed ID: 24773481
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients.
Bursi R; Piana C; Grevel J; Huntjens D; Boesl I
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):801-814. PubMed ID: 28078530
[TBL] [Abstract][Full Text] [Related]
26. Cognitive function in older patients with postherpetic neuralgia.
Pickering G; Pereira B; Clère F; Sorel M; de Montgazon G; Navez M; Picard P; Roux D; Morel V; Salimani R; Adda M; Legout V; Dubray C
Pain Pract; 2014 Jan; 14(1):E1-7. PubMed ID: 23701810
[TBL] [Abstract][Full Text] [Related]
27. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
28. Topical lidocaine for the treatment of postherpetic neuralgia.
Khaliq W; Alam S; Puri N
Cochrane Database Syst Rev; 2007 Apr; (2):CD004846. PubMed ID: 17443559
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy.
Martini A; Del Balzo G; Schweiger V; Zanzotti M; Picelli A; Parolini M; Chinellato E; Tamburin S; Polati E
Minerva Med; 2018 Oct; 109(5):344-351. PubMed ID: 29856191
[TBL] [Abstract][Full Text] [Related]
30. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
[TBL] [Abstract][Full Text] [Related]
31. Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry.
Überall MA; Eerdekens M; Hollanders E; Bösl I; Sabatschus I
Pain Manag; 2022 Mar; 12(2):195-209. PubMed ID: 34372662
[TBL] [Abstract][Full Text] [Related]
32. Topical pain management with the 5% lidocaine medicated plaster--a review.
Mick G; Correa-Illanes G
Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
[TBL] [Abstract][Full Text] [Related]
33. [Experience with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
Fogliardi A; Brunori C
Minerva Med; 2013 Dec; 104(6):631-7. PubMed ID: 24316916
[TBL] [Abstract][Full Text] [Related]
34. Patient perceptions associated with the 5% lidocaine medicated plaster in daily practice.
Überall MA; Müller-Schwefe GH
Curr Med Res Opin; 2012 Jun; 28(6):901-9. PubMed ID: 22506624
[TBL] [Abstract][Full Text] [Related]
35. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.
Davies PS; Galer BS
Drugs; 2004; 64(9):937-47. PubMed ID: 15101784
[TBL] [Abstract][Full Text] [Related]
36. Intrathecal methylprednisolone for intractable postherpetic neuralgia.
Kotani N; Kushikata T; Hashimoto H; Kimura F; Muraoka M; Yodono M; Asai M; Matsuki A
N Engl J Med; 2000 Nov; 343(21):1514-9. PubMed ID: 11087880
[TBL] [Abstract][Full Text] [Related]
37. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy.
Geha PY; Baliki MN; Chialvo DR; Harden RN; Paice JA; Apkarian AV
Pain; 2007 Mar; 128(1-2):88-100. PubMed ID: 17067740
[TBL] [Abstract][Full Text] [Related]
38. [Lidocaine tape (Penles--a dressing tape based on 60% lidocaine--) reduces the pain of postherpetic neuralgia].
Tamakawa S; Ogawa H
Masui; 1998 Jul; 47(7):882-4. PubMed ID: 9720343
[TBL] [Abstract][Full Text] [Related]
39. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
